Pazopanib-Induced Severe Acute Pancreatitis
Pazopanib is an oral angiogenesis inhibitor targeting vascular endothelial growth factor receptors, platelet-derived growth factor receptors, and c-Kit approved for the treatment of renal cell carcinoma and soft tissue sarcoma. Nonselective kinase inhibitors, such as sunitinib and sorafenib, are kno...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
S. Karger AG
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592502/ |